Invest in Viking Therapeutics and PayPal despite recent stock declines, offering long-term growth potential.

From Yahoo Finance: 2025-04-17 10:00:00

Equity markets have been turbulent due to President Trump’s economic policies, leading to stock declines. Two stocks to consider are Viking Therapeutics (NASDAQ: VKTX) and PayPal (NASDAQ: PYPL), both down at least 25% this year. Viking focuses on metabolic and endocrine disorder medicines, with promising data for candidates like VK2735 and VK2809. PayPal’s shares fell after a disappointing Q4, but the company’s strategic changes and strong brand make it a top fintech stock to buy. Despite recent struggles, both companies offer potential for long-term gains.

Investing in Viking Therapeutics and PayPal offers opportunities despite recent stock declines. Viking focuses on innovative therapies for metabolic disorders, showcasing promising candidates like VK2735 and VK2809. Meanwhile, PayPal, despite falling shares due to a weak Q4, remains a top fintech stock with strong brand recognition and strategic changes. Both companies present potential for patient investors seeking long-term growth.



Read more at Yahoo Finance: 2 Stocks Down by 25% or More This Year to Buy and Hold